ERIC HILMES: Open Payments
NPI 1902050388 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 58 payments from 12 companies in 2025. Trend: 2023 $2,731 · 2024 $2,534 · 2025 $1,640
Food & beverage: $1,555Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $452 |
| Arcutis Biotherapeutics, Inc. | 15 | $319 |
| ABBVIE INC. | 13 | $236 |
| Novartis Pharmaceuticals Corporation | 2 | $136 |
| Journey Medical Corporation | 1 | $131 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $104 |
| PFIZER INC. | 4 | $100 |
| LEO Pharma Inc. | 4 | $72 |
| Janssen Biotech, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: Bimzelx, Zoryve, SKYRIZI, RINVOQ, CIBINQO, ADBRY, TREMFYA, Sotyktu.
Industry payments across NV — which companies pay providers there.
